Academic Journal
Bone health in cancer. ESMO Clinical Practice Guidelines
| العنوان: | Bone health in cancer. ESMO Clinical Practice Guidelines |
|---|---|
| المؤلفون: | Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, Oudard S, Bruland O, Flamen P, Kurth A, Van Poznak C, Aapro M, Jordan K |
| المساهمون: | Coleman, R, Hadji, P, Body, Jj, Santini, D, Chow, E, Terpos, E, Oudard, S, Bruland, O, Flamen, P, Kurth, A, Van Poznak, C, Aapro, M, Jordan, K |
| سنة النشر: | 2020 |
| المجموعة: | Sapienza Università di Roma: CINECA IRIS |
| مصطلحات موضوعية: | bone metastase, cancer treatment-induced bone lo, bone-targeted agent, Clinical Practice Guideline, diagnosi, treatment, follow-up |
| الوصف: | The clinical course of advanced cancer for many patients with bone metastases can be transformed through optimum multidisciplinary management. • Bone-targeted agents significantly reduce skeletal morbidity in patients with bone metastases across tumour types and should be part of standard treatment. • Treatment-induced bone loss increases fracture risk and may require use of a bone-targeted agent in addition to lifestyle modifications. • The addition of a bisphosphonate to standard adjuvant therapies for postmenopausal early breast cancer reduces bone recurrence and improves survival. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/32801018; info:eu-repo/semantics/altIdentifier/wos/WOS:000591343500009; volume:31; issue:12; firstpage:1650; lastpage:1663; numberofpages:14; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/11573/1641614 |
| DOI: | 10.1016/j.annonc.2020.07.019 |
| الاتاحة: | https://hdl.handle.net/11573/1641614 https://doi.org/10.1016/j.annonc.2020.07.019 |
| Rights: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.43126872 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2020.07.019 |
|---|